+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Roche Diagnostics Ltd. - logo

Founded in Basel, Switzerland in 1896, Roche produces innovative medicines and diagnostic tests for the early detection, prevention, diagnosis and treatment of diseases including oncology, rheumatology, virology, transplantation, diabetes and immunology. They are the world’s leading biotech company and have been at the forefront of cancer research and treatment for more than 50 years, in addition to being the leading provider of in vitro diagnostics.

Whole Exome Sequencing - Global Strategic Business Report 2026 - Product Thumbnail Image

Whole Exome Sequencing - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 240 Pages
  • Global
From
Transfection Technologies - Global Strategic Business Report 2026 - Product Thumbnail Image

Transfection Technologies - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 221 Pages
  • Global
From
Carrier Screening - Global Strategic Business Report - Product Thumbnail Image

Carrier Screening - Global Strategic Business Report

  • Report
  • November 2026
  • 173 Pages
  • Global
From
From
Genotyping - Global Strategic Business Report 2026 - Product Thumbnail Image

Genotyping - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 215 Pages
  • Global
From
Genomics - Global Strategic Business Report 2026 - Product Thumbnail Image

Genomics - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 422 Pages
  • Global
From
Metastatic Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Metastatic Cancer Drugs - Global Strategic Business Report

  • Report
  • November 2026
  • 377 Pages
  • Global
From
Nasopharyngeal Cancer Treatment - Global Strategic Business Report - Product Thumbnail Image

Nasopharyngeal Cancer Treatment - Global Strategic Business Report

  • Report
  • November 2026
  • 288 Pages
  • Global
From
Personalized Cancer Medicines - Global Strategic Business Report - Product Thumbnail Image

Personalized Cancer Medicines - Global Strategic Business Report

  • Report
  • November 2026
  • 267 Pages
  • Global
From
From
Cytotoxic Drugs - Global Strategic Business Report - Product Thumbnail Image

Cytotoxic Drugs - Global Strategic Business Report

  • Report
  • November 2026
  • 462 Pages
  • Global
From
Cancer Biological Therapy - Global Strategic Business Report - Product Thumbnail Image

Cancer Biological Therapy - Global Strategic Business Report

  • Report
  • November 2026
  • 211 Pages
  • Global
From
Carcinoembryonic Antigen - Global Strategic Business Report - Product Thumbnail Image

Carcinoembryonic Antigen - Global Strategic Business Report

  • Report
  • November 2026
  • 485 Pages
  • Global
From
Peptide Drug Conjugates - Global Strategic Business Report - Product Thumbnail Image

Peptide Drug Conjugates - Global Strategic Business Report

  • Report
  • November 2026
  • 282 Pages
  • Global
From
Epithelioma Treatment - Global Strategic Business Report - Product Thumbnail Image

Epithelioma Treatment - Global Strategic Business Report

  • Report
  • November 2026
  • 380 Pages
  • Global
From
Retinoblastoma Treatment - Global Strategic Business Report - Product Thumbnail Image

Retinoblastoma Treatment - Global Strategic Business Report

  • Report
  • November 2026
  • 279 Pages
  • Global
From
Stomach Cancer Treatment - Global Strategic Business Report - Product Thumbnail Image

Stomach Cancer Treatment - Global Strategic Business Report

  • Report
  • November 2026
  • 371 Pages
  • Global
From
Antineoplastic Agents - Global Strategic Business Report - Product Thumbnail Image

Antineoplastic Agents - Global Strategic Business Report

  • Report
  • November 2026
  • 183 Pages
  • Global
From
From
Loading Indicator